Experts present information about recent advances in cardiovascular risk assessment and the burden of posttransplant major adverse cardiac events after liver transplant. Topics include the role of nuclear medicine positron emission tomography (NMPET) and computed tomography angiography (CTA) in cardiovascular risk stratification prior to liver transplant, and common cardiovascular complications posttransplant, including management approaches.
Review the role of nuclear medicine positron emission tomography (NMPET) and computed tomography angiography (CTA) in risk stratification for liver transplantation.
Describe common cardiovascular complications after liver transplant and management of these events.